The latest announcement is out from Zentek ( (TSE:ZEN) ).
Zentek Ltd. has successfully completed testing of its ZenARMOR™ nano-pigment technology in military-grade, chromate-free corrosion protection aerospace paint systems, in collaboration with the National Research Council of Canada. The tests demonstrated the effectiveness of ZenARMOR™ in preventing corrosion of aluminum alloy AA2024-T3. Following this success, Zentek has entered into a new collaboration with Jazeera Paints Company to further evaluate and develop ZenARMOR™ in their existing product lines. This partnership aims to leverage nanotechnology to enhance corrosion protection products, aligning with Jazeera Paints’ commitment to innovation in the construction industry across the Gulf Cooperation Council and the Middle East and North Africa region.
Spark’s Take on TSE:ZEN Stock
According to Spark, TipRanks’ AI Analyst, TSE:ZEN is a Underperform.
Zentek’s overall score reflects significant financial challenges, primarily due to persistent negative profitability and cash flow issues. While technical indicators and recent corporate events offer some hope, valuation concerns and potential financial liabilities from tax reassessments weigh heavily. Addressing these financial weaknesses will be crucial for improving the company’s stock performance.
To see Spark’s full report on TSE:ZEN stock, click here.
More about Zentek
Zentek Ltd. is an ISO 13485:2016 certified intellectual property technology company focused on the research, development, and commercialization of innovative products. The company aims to provide its commercial partners with a competitive edge by enhancing product safety, efficiency, and environmental friendliness. Zentek’s technology platform, ZenGUARD™, is known for improving bacterial and viral filtration efficiency in surgical masks and HVAC filters. Additionally, Zentek, through its subsidiary Triera Biosciences Ltd., holds a global exclusive license for an aptamer-based platform technology developed by McMaster University, targeting diagnostic and therapeutic markets.
YTD Price Performance: 9.69%
Average Trading Volume: 39,181
Technical Sentiment Signal: Hold
Current Market Cap: $118.2M
For an in-depth examination of ZEN stock, go to TipRanks’ Stock Analysis page.